Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice

Lotte Delemarre, Isabelle Huys, Walter Van Dyck, Steven Simoens

Open source

DOI
10.3389/fphar.2026.1749386
Published
2026-03-12
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1749386,
  title = {Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice},
  author = {Lotte Delemarre and Isabelle Huys and Walter Van Dyck and Steven Simoens},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1749386},
  url = {https://doi.org/10.3389/fphar.2026.1749386}
}

RIS

TY  - JOUR
TI  - Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice
AU  - Lotte Delemarre
AU  - Isabelle Huys
AU  - Walter Van Dyck
AU  - Steven Simoens
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1749386
UR  - https://doi.org/10.3389/fphar.2026.1749386
ER  - 

APA

Delemarre, L., Huys, I., Dyck, W. V., & Simoens, S. (2026). Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1749386

Source records